Europe
Amgen is suing Novartis, alleging a breach of the partnership and seeking to terminate the 2015 contract. Novartis, in response, filed a lawsuit accusing Amgen of inappropriately attempting to end the alliance.
Cytovant licenses East Asian rights for a research-stage T cell receptor (TCR) against tumor antigen NY-ESO-1 as well as rights for Medigene’s dendritic cell (DC) vaccine for the treatment of patients across East Asia
Independent Public Clinical Hospital No. 4 in Lublin is the first hospital outside of Germany to offer NanoTherm Therapy for the treatment of brain tumor patients
Single intravenous dose phase 1 trial showed that AIC649 was safe and well tolerated in all dose groups
Motif Bio plc, a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announced that four iclaprim abstracts have been accepted for presentation at the upcoming 28th European Congress of Clinical Microbiology and Infectious Diseases to be held in Amsterdam, The Netherlands, April 13-16, 2019.
Polyphor AG announced that 5 abstracts featuring data on its Outer Membrane Targeting Antibiotics, including both its lead product candidate murepavadin and its new medium-spectrum anti Gram-negative lead preclinical compound, will be presented at the 29th European Congress of Clinical Microbiology and Infectious Diseases taking place in Amsterdam, Netherlands, from April 13 to16, 2019.
The shares are trading on XETRA, the electronic trading platform of Deutsche Börse.
Pharma, biotech and life science companies strengthen leadership teams, with news from Vertex, Arvinas, Provention, Enterome, and more.
The government charged the three companies with using charitable foundations they financially supported to finance copays of Medicare and Medicaid patients, which is a violation of law.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
PRESS RELEASES